SENSORION
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
SENSORION
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Clapiers, Languedoc-Roussillon, France
Country:
France
Website Url:
http://www.sensorion.com
Total Employee:
11+
Status:
Active
Contact:
+33467207730
Email Addresses:
[email protected]
Total Funding:
4.75 M EUR
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS CDN JS PHP 7 ASP.NET IIS
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sanomune
Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-07-28 | Koubachi | Koubachi acquired by Sensorion | N/A |
Investors List
InnoBio Fund
InnoBio Fund investment in Venture Round - Sensorion
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Venture Round - Sensorion
Key Employee Changes
Official Site Inspections
http://www.sensorion.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Sensorion"
Sensorion - Crunchbase Company Profile & Funding
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.See details»
Présentation PowerPoint - Sensorion
Sensorion is focused on innovative treatments that can restore, treat and prevent hearing loss − Its oral small molecule asset SENS-401 currently in clinical development in the following …See details»
Sensorion Org Chart + Executive Team - The Official …
The org chart of Sensorion contains its 17 main executives including Nawal Ouzren, Laurene Danon and Bernd Schmidt.See details»
Sensorion - 2025 Company Profile, Funding & Competitors - Tracxn
Sensorion is a public company based in Montpellier (France), founded in 2009. It operates as a Developer of gene therapies for inner ear disorders. Sensorion has raised an undisclosed …See details»
Sensorion - VentureRadar
"Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to …See details»
Sensorion Publishes Results of Combined Shareholders’ General …
14 hours ago Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent …See details»
Sensorion Company Profile - Office Locations, Competitors ... - Craft
Sensorion has 5 employees at their 1 location. See insights on Sensorion including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Sensorion - Live Life with Unlimited Connections
Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner …See details»
Sensorion Publishes Results of Combined Shareholders ... - BioSpace
12 hours ago MONTPELLIER, France-- (BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in …See details»
Sensorion - Funding, Financials, Valuation & Investors
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.See details»
Sensorion Headquarters and Office Locations - Craft.co
Sensorion is headquartered in Montpellier, 375 Rue du Professeur Blayac, France, and has 1 office location.Sensorion Corporate Headquarters, Office Locations and Addresses | Craft.coSee details»
Sensorion - Contacts, Employees, Board Members, Advisors
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.See details»
A Brief History of Sensorion – CANVAS, SWOT, PESTEL & BCG …
Dec 19, 2024 A Brief History of Sensorion: Sensorion, a leading biotechnology company specializing in the development of innovative therapies for inner ear disorders, has a rich …See details»
Sensorion | VentureRadar
SENSORION France Publicly Traded Sensorion is a biopharmaceutical company, formed in 2009, focused as a “pure player” on developing therapies for debilitating inner ear disorders. With …See details»
Sensorion Publishes Results of Combined Shareholders’ General …
14 hours ago Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a …See details»
September2021 - sensorion.com
This document has been prepared by Sensorion (the «Company») and is provided for information purposes only. This document does not purport to contain comprehensive or complete …See details»
Sensorion SA - Drug pipelines, Patents, Clinical trials - Synapse
About Sensorion Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a …See details»
Medical Need - Sensorion
466 million people worldwide have disabling hearing loss (World Health Organization (WHO) 2020) 900 million people are expected to have disabling hearing loss by 2050 (WHO 2020)See details»
Sensorion Announces Approval of Shareholders’ Meeting …
19 hours ago On May 13, 2025, Sensorion, a biotechnology company focused on hearing loss therapies, reported the approval of all resolutions at its Combined General Meeting (CGM) …See details»
Sensorion Publishes Results of Combined Shareholders’ General …
14 hours ago Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a …See details»